CMLHope.Com
A Worldwide Support Network For Chronic Myelogenous Leukemia
Posted by rob on May 8, 2008 under Uncategorized | Be the First to Comment
BCR-ABL messenger RNA levels continue to decline in patients with chronic phase chronic myeloid leukemia treated with imatinib for more than 5 years and approximately half of all first-line treated patients have stable undetectable BCR-ABL using strict sensitivity criteria.
You must be logged in to post a comment.
Add A Comment
You must be logged in to post a comment.